-
1
Tissue-resident memory T cells in immune-related adverse events: friend or foe?
Published 2023-12-01Subjects: Get full text
Article -
2
CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies
Published 2025-01-01Subjects: “…immune-related adverse event (irAE)…”
Get full text
Article -
3
Pembrolizumab Induced Recall Dermatitis Occurring 5 Years After Radiotherapy
Published 2024-11-01Subjects: “…immune-related adverse event (irAE)…”
Get full text
Article -
4
-
5
Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related pneumonitis triggered by immunotherapy followed by radiation: a case report
Published 2024-11-01Subjects: “…immune-related adverse event (irAE)…”
Get full text
Article -
6
Correlation between thyroid dysfunction and efficacy of immune checkpoint inhibitors in patients with advanced solid tumors
Published 2024-11-01Subjects: Get full text
Article -
7
Immune-related thyroid dysfunction as a positive prognostic factor for patients with lung cancer in China: a real-world retrospective study
Published 2024-12-01Subjects: Get full text
Article -
8
Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis
Published 2025-01-01Subjects: “…immune-related adverse events (irAEs)…”
Get full text
Article -
9
Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the litera...
Published 2024-12-01Subjects: “…immune-related adverse events (irAEs)…”
Get full text
Article -
10
The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment
Published 2024-12-01Subjects: Get full text
Article -
11
Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity
Published 2024-12-01Subjects: “…immune-related adverse events (irAEs)…”
Get full text
Article -
12
Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analy...
Published 2024-12-01Subjects: “…immune related adverse events (irAEs)…”
Get full text
Article